[1]
Rada, F.H. 2020. Adequacy of Olmesartan monotherapy versus cotherapy in patients with essential hypertension. International Journal of Research in Pharmaceutical Sciences. 11, 2 (Apr. 2020), 1649-1654. DOI:https://doi.org/10.26452/ijrps.v11i2.2047.